PPARγ: A Target for Cancer Prevention
Author Information
Author(s): Ioannis Sainis, Katerina Vareli, Vasilios Karavasilis, Evangelos Briasoulis
Primary Institution: University of Ioannina
Hypothesis
Can PPARγ ligands serve as effective cancer chemopreventive agents?
Conclusion
PPARγ is a promising target for cancer chemoprevention, but clinical trials have not yet shown significant benefits.
Supporting Evidence
- PPARγ is involved in important processes like cell differentiation and apoptosis, which are crucial in cancer.
- PPARγ ligands have shown early antineoplastic effects in various tumor types.
- Natural products that activate PPARγ may help in cancer prevention.
Takeaway
PPARγ is like a helper that can stop cancer from growing, but scientists are still figuring out how to use it best.
Methodology
The article reviews existing studies on PPARγ and its role in cancer prevention.
Potential Biases
Potential off-target effects of PPARγ ligands may complicate their use in cancer prevention.
Limitations
Clinical trials have not demonstrated significant benefits of PPARγ ligands in cancer prevention.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website